Muutke küpsiste eelistusi

Understanding and Managing Neurodevelopmental Disorders in Children and Adolescents: A Pediatric Treatment Guide [Kõva köide]

Edited by , Edited by , Edited by , Edited by , Edited by
  • Formaat: Hardback, 326 pages, kõrgus x laius: 229x152 mm, kaal: 800 g, 8 Tables, black and white; 1 Halftones, black and white; 1 Illustrations, black and white
  • Ilmumisaeg: 11-May-2025
  • Kirjastus: Routledge
  • ISBN-10: 103268447X
  • ISBN-13: 9781032684475
  • Formaat: Hardback, 326 pages, kõrgus x laius: 229x152 mm, kaal: 800 g, 8 Tables, black and white; 1 Halftones, black and white; 1 Illustrations, black and white
  • Ilmumisaeg: 11-May-2025
  • Kirjastus: Routledge
  • ISBN-10: 103268447X
  • ISBN-13: 9781032684475

Children are being identified with more neurodevelopmental disorders than in previous decades and understanding these medically complex disorders has become critical as more children are living with these disorders.

This pediatric treatment guide provides cutting-edge research and intervention recommendations for professionals working with children and adolescents. A team of contributors with diverse experience portray medically complex information and neurodevelopmental disorders in an accessible manner. Chapters include information on a range of disorders, such as: cystic fibrosis, diabetes, epilepsy, meningitis, chronic fatigue, and more. Each disorder’s physical and neurological manifestations are explored, as well as how the disorder is diagnosed and treated, and information regarding appropriate assessment and intervention. A list of further resources is included at the end of most chapters.

This book is essential for practitioners working with children, including clinical psychologists, school psychologists, child neuropsychologists, clinical and school social workers, school nurses, pediatricians, and graduate students in training within various pediatric specialties.



Children are being identified with more neurodevelopmental disorders than in previous decades and understanding these medically complex disorders has become critical as more children are living with these disorders.

Arvustused

A diverse group of esteemed experts provides an outstanding summary on an impressive number of medical conditions that impact neuropsychological functioning in children and adolescents. Implications for academic functioning are illustrated eloquently by way of case examples and pertinent research findings that provide practitioners with a basis for planning appropriate testing batteries. This is a fantastic resource that provides a quick, yet thorough background for practitioners who see children and adolescents with a variety of medical conditions along with expectations for potential outcomes.

Beth Colaluca, PhD, department of Neuropsychology/Neurosciences, Cook Childrens Medical Center Fort Worth, Texas

This is a handbook that clinicians will want to keep close as they navigate through the assessment and treatment of children and adolescents with neurodevelopmental disorders. It is a well written and clinically practical volume that will give the reader the essential information needed to guide differential diagnosis, assessment, and intervention approaches: An essential and hands-on resource for all levels of applied practice!

Elaine Fletcher-Janzen, Ed.D., NCSP, ABPdN, diplomate, American Board of Pediatric Neuropsychology, private practice, Niles, Michigan

Section 1: Neurodevelopmental Disorders An Introduction
1. Advancing Practice in Neurodevelopment
2. School Integration for Children with Medical/Physical Disorders and Complex Medical Needs
3. Prematurity and Related Complications Section 2: Metabolix, Toxic, and Inflammatory Disorders
4. Inflammation of the Brain: Pediatric Encephalitis and Meningitis
5. Neonatal Abstinence Syndrome (NAS)
6. Fetal Alcohol Spectrum Disorders (FASDs)
7. Neurotoxins and Pediatric Poisoning
8. Viral Infections
9. Covid-19 and Long Covid in Children
10. Autoimmune Disorders: Pediatric Myalgic Encephalomyelitis/Chronic Fatigue (ME/CFS), Pediatric Gullain Barre Syndrome (GBS) and Juvenile Fribomyalgia Syndrome (JPFS)
11. Juvenile Arthritis
12. Postural Orthostatic Tachycardia Syndrome (POTS) and Ehlers Danlos Syndrome (EDS) in Pediatric Patients Section 3: Medically Complex Disorders
13. Epilepsy and Seizures in Children and Adolescents
14. Evaulation and Management of Neurocognitive Dysfunction in Children and Adolescents with Type 1 Diabetes
15. Pediatric Stroke/Cardiovascular Accident (CVA) Section 4: Genetic and Chromosomal Disorders
16. Sickle Cell Disease (SCD)
17. Cystic Fibrosis
18. Genetic Disorders Impacting Cognition
19. Deletion Disorders
20. Neurofibromatosis Type 1 and Neurofibromatosis Type 2-Related Schwannomatosis Section 5: Malformations of Brain and Spine
21. Spina Bifida
22. Chiari Malformation
23. Cerebral Palsy
24. Demyelinating Disorders Index

Denise E. Maricle, Ph.D., LP-MN, NCSP, ABSNP retired from academia in 2023. Over the past 30+ years, Dr. Maricle has practiced as a psychologist, school psychologist, pediatric/school neuropsychologist, and an academician and researcher. She currently engages in writing, training, and consultancy work.

Christopher L. Bedford, Ph.D., LP, ABSNP is the executive director of the American Board of School Neuropsychology. Working as a psychologist for more than 15 years, Dr. Bedford currently operates a private practice in Minnesota.

Julie A. Gettman, Ph.D., NCSP, ABSNP is the executive director of the School Neuropsychology Institute. She owns and operates Mindworks Assessment, a private practice and consulting company specializing in comprehensive neurocognitive assessment for children and adolescents.

Daniel C. Miller, Ph.D., ABPP, ABSNP is the founder of the School Neuropsychology Institute, president of KIDS, Inc., and founder of Report Insights LLC. He has more than 35+ years of experience in school psychology and school neuropsychology. He is the executive director of the Woodcock Institute for Neurocognitive Research and Applied Practice.

Wendi L. Johnson, Ph.D., LP, NCSP, LSSP is an associate professor at Texas Woman's University, and the assistant executive director of the Woodcock Institute for Neurocognitive Research and Applied Practice. Dr. Johnson currently serves as director of the Woodcock Autism Assessment Clinic (WAAC).